市場調査レポート
商品コード
1491604

肺がん治療薬の世界市場 2024-2028

Global lung cancer therapeutics market 2024-2028

出版日: | 発行: TechNavio | ページ情報: 英文 171 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
肺がん治療薬の世界市場 2024-2028
出版日: 2024年05月22日
発行: TechNavio
ページ情報: 英文 171 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

肺がん治療薬市場は2023-2028年に105億2,770万米ドル、予測期間中のCAGRは7.69%で成長すると予測されます。

当レポートでは、肺がん治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、免疫調節薬の大きな貢献、肺がんの旺盛な有病率、患者支援プログラムの増加によって牽引されています。

市場範囲
基準年 2024
終了年 2028
予測期間 2024-2028
成長モメンタム 加速
前年比2024年 6.99%
CAGR 7.69%
増分額 105億2,770万米ドル

本調査では、再生療法の登場が今後数年間の肺がん治療薬市場成長を牽引する主要因の1つであるとしています。また、戦略的提携の増加やタンパク質バイオマーカーの出現は、同市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム
  • 市場の特徴
  • バリューチェーン分析

第3章 市場規模の評価

  • 市場の定義
  • 市場セグメント分析
  • 市場規模 2023
  • 市場の見通し 2023-2028

第4章 市場規模実績

  • 世界肺がん治療薬市場 2018-2022
  • 治療セグメント分析 2018-2022
  • タイプセグメント分析 2018-2022
  • 地域別セグメント分析 2018-2022
  • 国別セグメント分析 2018-2022

第5章 ファイブフォース分析

  • ファイブフォースの要約
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争の脅威
  • 市況

第6章 市場セグメンテーション:治療法別

  • 市場セグメンテーション
  • 比較:治療法別
  • 標的療法:市場規模と予測 2023-2028
  • 免疫療法:市場規模と予測 2023-2028
  • 化学療法:市場規模と予測 2023-2028
  • 市場機会セラピー

第7章 市場セグメンテーション:タイプ別

  • 市場セグメンテーション
  • 比較:タイプ別
  • 非小細胞肺がん:市場規模と予測 2023-2028
  • 肺小細胞癌:市場規模と予測 2023-2028
  • 市場機会:タイプ別

第8章 顧客情勢

  • 顧客情勢の概要

第9章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米:市場規模と予測 2023-2028
  • 欧州:市場規模と予測 2023-2028
  • アジア:市場規模と予測 2023-2028
  • 世界のその他の地域:市場規模と予測 2023-2028
  • 米国:市場規模と予測 2023-2028
  • 英国:市場規模と予測 2023-2028
  • カナダ:市場規模と予測 2023-2028
  • 中国:市場規模と予測 2023-2028
  • フランス:市場規模と予測 2023-2028
  • 市場機会:地域情勢別

第10章 促進要因・課題・機会・抑制要因

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場の機会・抑制要因

第11章 競合情勢

  • 概要
  • 競合情勢
  • 混乱の状況
  • 業界のリスク

第12章 競合分析

  • 企業プロファイル
  • 企業の市場ポジショニング
  • AbbVie Inc.
  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca Plc
  • Boehringer Ingelheim International GmbH
  • Bristol Myers Squibb Co.
  • Daiichi Sankyo Co. Ltd.
  • Eli Lilly and Co.
  • F. Hoffmann La Roche Ltd.
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.

第13章 付録

図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Therapy
  • Exhibits6: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits7: Executive Summary - Chart on Incremental Growth
  • Exhibits8: Executive Summary - Data Table on Incremental Growth
  • Exhibits9: Executive Summary - Chart on Company Market Positioning
  • Exhibits10: Parent Market
  • Exhibits11: Data Table on - Parent Market
  • Exhibits12: Market characteristics analysis
  • Exhibits13: Value Chain Analysis
  • Exhibits14: Offerings of companies included in the market definition
  • Exhibits15: Market segments
  • Exhibits16: Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Exhibits18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
  • Exhibits20: Historic Market Size - Data Table on Global Lung Cancer Therapeutics Market 2018 - 2022 ($ million)
  • Exhibits21: Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
  • Exhibits22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • Exhibits23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • Exhibits24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
  • Exhibits25: Five forces analysis - Comparison between 2023 and 2028
  • Exhibits26: Bargaining power of buyers - Impact of key factors 2023 and 2028
  • Exhibits27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • Exhibits28: Threat of new entrants - Impact of key factors in 2023 and 2028
  • Exhibits29: Threat of substitutes - Impact of key factors in 2023 and 2028
  • Exhibits30: Threat of rivalry - Impact of key factors in 2023 and 2028
  • Exhibits31: Chart on Market condition - Five forces 2023 and 2028
  • Exhibits32: Chart on Therapy - Market share 2023-2028 (%)
  • Exhibits33: Data Table on Therapy - Market share 2023-2028 (%)
  • Exhibits34: Chart on Comparison by Therapy
  • Exhibits35: Data Table on Comparison by Therapy
  • Exhibits36: Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits37: Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits38: Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits39: Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
  • Exhibits40: Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits41: Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits42: Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits43: Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits44: Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits45: Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
  • Exhibits46: Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits47: Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
  • Exhibits48: Market opportunity by Therapy ($ million)
  • Exhibits49: Data Table on Market opportunity by Therapy ($ million)
  • Exhibits50: Chart on Type - Market share 2023-2028 (%)
  • Exhibits51: Data Table on Type - Market share 2023-2028 (%)
  • Exhibits52: Chart on Comparison by Type
  • Exhibits53: Data Table on Comparison by Type
  • Exhibits54: Chart on NSCLC - Market size and forecast 2023-2028 ($ million)
  • Exhibits55: Data Table on NSCLC - Market size and forecast 2023-2028 ($ million)
  • Exhibits56: Chart on NSCLC - Year-over-year growth 2023-2028 (%)
  • Exhibits57: Data Table on NSCLC - Year-over-year growth 2023-2028 (%)
  • Exhibits58: Chart on SCLC - Market size and forecast 2023-2028 ($ million)
  • Exhibits59: Data Table on SCLC - Market size and forecast 2023-2028 ($ million)
  • Exhibits60: Chart on SCLC - Year-over-year growth 2023-2028 (%)
  • Exhibits61: Data Table on SCLC - Year-over-year growth 2023-2028 (%)
  • Exhibits62: Market opportunity by Type ($ million)
  • Exhibits63: Data Table on Market opportunity by Type ($ million)
  • Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits65: Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits66: Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • Exhibits67: Chart on Geographic comparison
  • Exhibits68: Data Table on Geographic comparison
  • Exhibits69: Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits70: Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Exhibits71: Chart on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits72: Data Table on North America - Year-over-year growth 2023-2028 (%)
  • Exhibits73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Exhibits75: Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • Exhibits77: Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits78: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Exhibits79: Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits80: Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Exhibits85: Chart on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits86: Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Exhibits87: Chart on US - Year-over-year growth 2023-2028 (%)
  • Exhibits88: Data Table on US - Year-over-year growth 2023-2028 (%)
  • Exhibits89: Chart on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits90: Data Table on UK - Market size and forecast 2023-2028 ($ million)
  • Exhibits91: Chart on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits92: Data Table on UK - Year-over-year growth 2023-2028 (%)
  • Exhibits93: Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits94: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Exhibits95: Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits96: Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • Exhibits97: Chart on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits98: Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Exhibits99: Chart on China - Year-over-year growth 2023-2028 (%)
  • Exhibits100: Data Table on China - Year-over-year growth 2023-2028 (%)
  • Exhibits101: Chart on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits102: Data Table on France - Market size and forecast 2023-2028 ($ million)
  • Exhibits103: Chart on France - Year-over-year growth 2023-2028 (%)
  • Exhibits104: Data Table on France - Year-over-year growth 2023-2028 (%)
  • Exhibits105: Market opportunity By Geographical Landscape ($ million)
  • Exhibits106: Data Tables on Market opportunity By Geographical Landscape ($ million)
  • Exhibits107: Impact of drivers and challenges in 2023 and 2028
  • Exhibits108: Overview on criticality of inputs and factors of differentiation
  • Exhibits109: Overview on factors of disruption
  • Exhibits110: Impact of key risks on business
  • Exhibits111: Companies covered
  • Exhibits112: Matrix on companies position and classification
  • Exhibits113: AbbVie Inc. - Overview
  • Exhibits114: AbbVie Inc. - Product / Service
  • Exhibits115: AbbVie Inc. - Key news
  • Exhibits116: AbbVie Inc. - Key offerings
  • Exhibits117: Amgen Inc. - Overview
  • Exhibits118: Amgen Inc. - Product / Service
  • Exhibits119: Amgen Inc. - Key news
  • Exhibits120: Amgen Inc. - Key offerings
  • Exhibits121: Astellas Pharma Inc. - Overview
  • Exhibits122: Astellas Pharma Inc. - Product / Service
  • Exhibits123: Astellas Pharma Inc. - Key news
  • Exhibits124: Astellas Pharma Inc. - Key offerings
  • Exhibits125: AstraZeneca Plc - Overview
  • Exhibits126: AstraZeneca Plc - Product / Service
  • Exhibits127: AstraZeneca Plc - Key news
  • Exhibits128: AstraZeneca Plc - Key offerings
  • Exhibits129: Boehringer Ingelheim International GmbH - Overview
  • Exhibits130: Boehringer Ingelheim International GmbH - Product / Service
  • Exhibits131: Boehringer Ingelheim International GmbH - Key news
  • Exhibits132: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits133: Bristol Myers Squibb Co. - Overview
  • Exhibits134: Bristol Myers Squibb Co. - Product / Service
  • Exhibits135: Bristol Myers Squibb Co. - Key news
  • Exhibits136: Bristol Myers Squibb Co. - Key offerings
  • Exhibits137: Daiichi Sankyo Co. Ltd. - Overview
  • Exhibits138: Daiichi Sankyo Co. Ltd. - Product / Service
  • Exhibits139: Daiichi Sankyo Co. Ltd. - Key news
  • Exhibits140: Daiichi Sankyo Co. Ltd. - Key offerings
  • Exhibits141: Eli Lilly and Co. - Overview
  • Exhibits142: Eli Lilly and Co. - Product / Service
  • Exhibits143: Eli Lilly and Co. - Key news
  • Exhibits144: Eli Lilly and Co. - Key offerings
  • Exhibits145: F. Hoffmann La Roche Ltd. - Overview
  • Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
  • Exhibits147: F. Hoffmann La Roche Ltd. - Key news
  • Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
  • Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
  • Exhibits150: GlaxoSmithKline Plc - Overview
  • Exhibits151: GlaxoSmithKline Plc - Business segments
  • Exhibits152: GlaxoSmithKline Plc - Key news
  • Exhibits153: GlaxoSmithKline Plc - Key offerings
  • Exhibits154: GlaxoSmithKline Plc - Segment focus
  • Exhibits155: Merck and Co. Inc. - Overview
  • Exhibits156: Merck and Co. Inc. - Business segments
  • Exhibits157: Merck and Co. Inc. - Key news
  • Exhibits158: Merck and Co. Inc. - Key offerings
  • Exhibits159: Merck and Co. Inc. - Segment focus
  • Exhibits160: Novartis AG - Overview
  • Exhibits161: Novartis AG - Business segments
  • Exhibits162: Novartis AG - Key news
  • Exhibits163: Novartis AG - Key offerings
  • Exhibits164: Novartis AG - Segment focus
  • Exhibits165: Pfizer Inc. - Overview
  • Exhibits166: Pfizer Inc. - Product / Service
  • Exhibits167: Pfizer Inc. - Key news
  • Exhibits168: Pfizer Inc. - Key offerings
  • Exhibits169: Sanofi SA - Overview
  • Exhibits170: Sanofi SA - Business segments
  • Exhibits171: Sanofi SA - Key news
  • Exhibits172: Sanofi SA - Key offerings
  • Exhibits173: Sanofi SA - Segment focus
  • Exhibits174: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits175: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits176: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits177: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits178: Inclusions checklist
  • Exhibits179: Exclusions checklist
  • Exhibits180: Currency conversion rates for US$
  • Exhibits181: Research methodology
  • Exhibits182: Information sources
  • Exhibits183: Data validation
  • Exhibits184: Validation techniques employed for market sizing
  • Exhibits185: Data synthesis
  • Exhibits186: 360 degree market analysis
  • Exhibits187: List of abbreviations
目次
Product Code: IRTNTR71021

The lung cancer therapeutics market is forecasted to grow by USD 10527.7 mn during 2023-2028, accelerating at a CAGR of 7.69% during the forecast period. The report on the lung cancer therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by heavy contribution of immunomodulators, strong prevalence of lung cancer, and increasing number of patient assistance programs.

Technavio's lung cancer therapeutics market is segmented as below:

Market Scope
Base Year2024
End Year2028
Series Year2024-2028
Growth MomentumAccelerate
YOY 20246.99%
CAGR7.69%
Incremental Value$10527.7mn

ByTherapy

  • Targeted therapy
  • Immunotherapy
  • Chemotherapy

ByType

  • NSCLC
  • SCLC

ByGeography

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the advent of regenerative therapies as one of the prime reasons driving the lung cancer therapeutics market growth during the next few years. Also, increasing strategic alliances and advent of protein biomarkers will lead to sizable demand in the market.

The report on the lung cancer therapeutics market covers the following areas:

  • Lung cancer therapeutics market sizing
  • Lung cancer therapeutics market forecast
  • Lung cancer therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lung cancer therapeutics market vendors that include AbbVie Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca Plc, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., Galecto Inc., GlaxoSmithKline Plc, IOVANCE Biotherapeutics Inc., Johnson and Johnson Services Inc., Merck and Co. Inc., Moderna Inc., Novartis AG, Parexel International Corp., Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd.. Also, the lung cancer therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Therapy
    • Executive Summary - Chart on Market Segmentation by Type
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 2.2 Market characteristics
    • Market characteristics analysis
  • 2.3 Value chain analysis
    • Value Chain Analysis

3 Market Sizing

  • 3.1 Market definition
    • Offerings of companies included in the market definition
  • 3.2 Market segment analysis
    • Market segments
  • 3.3 Market size 2023
  • 3.4 Market outlook: Forecast for 2023-2028
    • Chart on Global - Market size and forecast 2023-2028 ($ million)
    • Data Table on Global - Market size and forecast 2023-2028 ($ million)
    • Chart on Global Market: Year-over-year growth 2023-2028 (%)
    • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

  • 4.1 Global Lung Cancer Therapeutics Market 2018 - 2022
    • Historic Market Size - Data Table on Global Lung Cancer Therapeutics Market 2018 - 2022 ($ million)
  • 4.2 Therapy segment analysis 2018 - 2022
    • Historic Market Size - Therapy Segment 2018 - 2022 ($ million)
  • 4.3 Type segment analysis 2018 - 2022
    • Historic Market Size - Type Segment 2018 - 2022 ($ million)
  • 4.4 Geography segment analysis 2018 - 2022
    • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
  • 4.5 Country segment analysis 2018 - 2022
    • Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary
    • Five forces analysis - Comparison between 2023 and 2028
  • 5.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2023 and 2028
  • 5.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
  • 5.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2023 and 2028
  • 5.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2023 and 2028
  • 5.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2023 and 2028
  • 5.7 Market condition
    • Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Therapy

  • 6.1 Market segments
    • Chart on Therapy - Market share 2023-2028 (%)
    • Data Table on Therapy - Market share 2023-2028 (%)
  • 6.2 Comparison by Therapy
    • Chart on Comparison by Therapy
    • Data Table on Comparison by Therapy
  • 6.3 Targeted therapy - Market size and forecast 2023-2028
    • Chart on Targeted therapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Targeted therapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Targeted therapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Targeted therapy - Year-over-year growth 2023-2028 (%)
  • 6.4 Immunotherapy - Market size and forecast 2023-2028
    • Chart on Immunotherapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Immunotherapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Immunotherapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Immunotherapy - Year-over-year growth 2023-2028 (%)
  • 6.5 Chemotherapy - Market size and forecast 2023-2028
    • Chart on Chemotherapy - Market size and forecast 2023-2028 ($ million)
    • Data Table on Chemotherapy - Market size and forecast 2023-2028 ($ million)
    • Chart on Chemotherapy - Year-over-year growth 2023-2028 (%)
    • Data Table on Chemotherapy - Year-over-year growth 2023-2028 (%)
  • 6.6 Market opportunity by Therapy
    • Market opportunity by Therapy ($ million)
    • Data Table on Market opportunity by Therapy ($ million)

7 Market Segmentation by Type

  • 7.1 Market segments
    • Chart on Type - Market share 2023-2028 (%)
    • Data Table on Type - Market share 2023-2028 (%)
  • 7.2 Comparison by Type
    • Chart on Comparison by Type
    • Data Table on Comparison by Type
  • 7.3 NSCLC - Market size and forecast 2023-2028
    • Chart on NSCLC - Market size and forecast 2023-2028 ($ million)
    • Data Table on NSCLC - Market size and forecast 2023-2028 ($ million)
    • Chart on NSCLC - Year-over-year growth 2023-2028 (%)
    • Data Table on NSCLC - Year-over-year growth 2023-2028 (%)
  • 7.4 SCLC - Market size and forecast 2023-2028
    • Chart on SCLC - Market size and forecast 2023-2028 ($ million)
    • Data Table on SCLC - Market size and forecast 2023-2028 ($ million)
    • Chart on SCLC - Year-over-year growth 2023-2028 (%)
    • Data Table on SCLC - Year-over-year growth 2023-2028 (%)
  • 7.5 Market opportunity by Type
    • Market opportunity by Type ($ million)
    • Data Table on Market opportunity by Type ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2023-2028 (%)
    • Data Table on Market share By Geographical Landscape 2023-2028 (%)
  • 9.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2023-2028
    • Chart on North America - Market size and forecast 2023-2028 ($ million)
    • Data Table on North America - Market size and forecast 2023-2028 ($ million)
    • Chart on North America - Year-over-year growth 2023-2028 (%)
    • Data Table on North America - Year-over-year growth 2023-2028 (%)
  • 9.4 Europe - Market size and forecast 2023-2028
    • Chart on Europe - Market size and forecast 2023-2028 ($ million)
    • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
    • Chart on Europe - Year-over-year growth 2023-2028 (%)
    • Data Table on Europe - Year-over-year growth 2023-2028 (%)
  • 9.5 Asia - Market size and forecast 2023-2028
    • Chart on Asia - Market size and forecast 2023-2028 ($ million)
    • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
    • Chart on Asia - Year-over-year growth 2023-2028 (%)
    • Data Table on Asia - Year-over-year growth 2023-2028 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
    • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • 9.7 US - Market size and forecast 2023-2028
    • Chart on US - Market size and forecast 2023-2028 ($ million)
    • Data Table on US - Market size and forecast 2023-2028 ($ million)
    • Chart on US - Year-over-year growth 2023-2028 (%)
    • Data Table on US - Year-over-year growth 2023-2028 (%)
  • 9.8 UK - Market size and forecast 2023-2028
    • Chart on UK - Market size and forecast 2023-2028 ($ million)
    • Data Table on UK - Market size and forecast 2023-2028 ($ million)
    • Chart on UK - Year-over-year growth 2023-2028 (%)
    • Data Table on UK - Year-over-year growth 2023-2028 (%)
  • 9.9 Canada - Market size and forecast 2023-2028
    • Chart on Canada - Market size and forecast 2023-2028 ($ million)
    • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
    • Chart on Canada - Year-over-year growth 2023-2028 (%)
    • Data Table on Canada - Year-over-year growth 2023-2028 (%)
  • 9.10 China - Market size and forecast 2023-2028
    • Chart on China - Market size and forecast 2023-2028 ($ million)
    • Data Table on China - Market size and forecast 2023-2028 ($ million)
    • Chart on China - Year-over-year growth 2023-2028 (%)
    • Data Table on China - Year-over-year growth 2023-2028 (%)
  • 9.11 France - Market size and forecast 2023-2028
    • Chart on France - Market size and forecast 2023-2028 ($ million)
    • Data Table on France - Market size and forecast 2023-2028 ($ million)
    • Chart on France - Year-over-year growth 2023-2028 (%)
    • Data Table on France - Year-over-year growth 2023-2028 (%)
  • 9.12 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2023 and 2028
  • 10.4 Market opportunities/restraints

11 Competitive Landscape

  • 11.1 Overview
  • 11.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 11.3 Landscape disruption
    • Overview on factors of disruption
  • 11.4 Industry risks
    • Impact of key risks on business

12 Competitive Analysis

  • 12.1 Companies profiled
    • Companies covered
  • 12.2 Market positioning of companies
    • Matrix on companies position and classification
  • 12.3 AbbVie Inc.
    • AbbVie Inc. - Overview
    • AbbVie Inc. - Product / Service
    • AbbVie Inc. - Key news
    • AbbVie Inc. - Key offerings
  • 12.4 Amgen Inc.
    • Amgen Inc. - Overview
    • Amgen Inc. - Product / Service
    • Amgen Inc. - Key news
    • Amgen Inc. - Key offerings
  • 12.5 Astellas Pharma Inc.
    • Astellas Pharma Inc. - Overview
    • Astellas Pharma Inc. - Product / Service
    • Astellas Pharma Inc. - Key news
    • Astellas Pharma Inc. - Key offerings
  • 12.6 AstraZeneca Plc
    • AstraZeneca Plc - Overview
    • AstraZeneca Plc - Product / Service
    • AstraZeneca Plc - Key news
    • AstraZeneca Plc - Key offerings
  • 12.7 Boehringer Ingelheim International GmbH
    • Boehringer Ingelheim International GmbH - Overview
    • Boehringer Ingelheim International GmbH - Product / Service
    • Boehringer Ingelheim International GmbH - Key news
    • Boehringer Ingelheim International GmbH - Key offerings
  • 12.8 Bristol Myers Squibb Co.
    • Bristol Myers Squibb Co. - Overview
    • Bristol Myers Squibb Co. - Product / Service
    • Bristol Myers Squibb Co. - Key news
    • Bristol Myers Squibb Co. - Key offerings
  • 12.9 Daiichi Sankyo Co. Ltd.
    • Daiichi Sankyo Co. Ltd. - Overview
    • Daiichi Sankyo Co. Ltd. - Product / Service
    • Daiichi Sankyo Co. Ltd. - Key news
    • Daiichi Sankyo Co. Ltd. - Key offerings
  • 12.10 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key news
    • Eli Lilly and Co. - Key offerings
  • 12.11 F. Hoffmann La Roche Ltd.
    • F. Hoffmann La Roche Ltd. - Overview
    • F. Hoffmann La Roche Ltd. - Business segments
    • F. Hoffmann La Roche Ltd. - Key news
    • F. Hoffmann La Roche Ltd. - Key offerings
    • F. Hoffmann La Roche Ltd. - Segment focus
  • 12.12 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
  • 12.13 Merck and Co. Inc.
    • Merck and Co. Inc. - Overview
    • Merck and Co. Inc. - Business segments
    • Merck and Co. Inc. - Key news
    • Merck and Co. Inc. - Key offerings
    • Merck and Co. Inc. - Segment focus
  • 12.14 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
  • 12.15 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
  • 12.16 Sanofi SA
    • Sanofi SA - Overview
    • Sanofi SA - Business segments
    • Sanofi SA - Key news
    • Sanofi SA - Key offerings
    • Sanofi SA - Segment focus
  • 12.17 Takeda Pharmaceutical Co. Ltd.
    • Takeda Pharmaceutical Co. Ltd. - Overview
    • Takeda Pharmaceutical Co. Ltd. - Product / Service
    • Takeda Pharmaceutical Co. Ltd. - Key news
    • Takeda Pharmaceutical Co. Ltd. - Key offerings

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 13.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 13.4 Research methodology
    • Research methodology
  • 13.5 Data procurement
    • Information sources
  • 13.6 Data validation
    • Data validation
  • 13.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 13.8 Data synthesis
    • Data synthesis
  • 13.9 360 degree market analysis
    • 360 degree market analysis
  • 13.10 List of abbreviations
    • List of abbreviations